HOOKIPA Pharma Inc. (HOOK) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 5 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for HOOK is $3.00, representing a +167.9% upside from the current price of $1.12. Price targets range from a low of $3.00 to a high of $3.00.
